Through various functional studies, it is discerned that a surge in METTL7B expression counteracts the invasive tendencies of breast cancer cells and concurrently rectifies the Golgi disintegration brought on by RhoBTB1 insufficiency [59]. The gene discussed is TMT1B; the disease is breast carcinoma.